SCHEMBL21414342

SCHEMBL21414342

CCc1ccc(CN2CCC(O)CC2)cn1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ CYP2D6 P10635 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ NPC1 O15118 1/20 0.47
▸ CD274 Q9NZQ7 2/20 0.47
▸ MAPT P10636 1/20 0.45
▸ HRH3 Q9Y5N1 5/20 0.44
▸ ACHE P22303 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ SPHK1 Q9NYA1 1/20 0.43
▸ HTR2A P28223 1/20 0.42
▸ MCHR1 Q99705 1/20 0.42
▸ PDCD1 Q15116 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21414344 0.86 HRH3 (0.46) RAB9AKMT2AALDH1A1CYP2D6MEN1
SCHEMBL20356732 0.83 HRH3 (0.62) KMT2AALDH1A1CYP2D6MEN1HRH3
SCHEMBL18291674 0.82 RAB9A (0.54) RAB9AKMT2AALDH1A1CYP2D6MEN1
SCHEMBL20443001 0.81 ALDH1A1 (0.54) RAB9AKMT2AALDH1A1CYP2D6MEN1
SCHEMBL25728960 0.81 CYP1A2 (0.63) KMT2AALDH1A1CYP2D6MEN1HRH3
SCHEMBL10289221 0.80 LMNA (0.51) RAB9AKMT2AALDH1A1CYP2D6MEN1
SCHEMBL22876983 0.80 KMT2A (0.42) RAB9AKMT2AALDH1A1CYP2D6MEN1
SCHEMBL21414363 0.79 ALDH1A1 (0.55) RAB9AKMT2AALDH1A1CYP2D6MEN1
SCHEMBL8244953 0.79 ALDH1A1 (0.65) RAB9AKMT2AALDH1A1CYP2D6MEN1
SCHEMBL18291538 0.79 RAB9A (0.52) RAB9AKMT2AALDH1A1CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 — — EP disclosed
EP-3546458-A1 PYRIDO[3, 4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2019-10-02 — — EP disclosed
Send feedback